Cargando…

Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for “late-onset” hypogonadism: A case report

For obese type 2 diabetes patients, weight reduction is one of the most important measures but fails in most cases. Testosterone deficiency can be the reason for such failure. This case presents a 57-year-old man who was referred to a urologist due to benign prostatic hyperplasia and erectile dysfun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haider, Ahmad, Haider, Karim, Saad, Farid, Hanefeld, Markolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349975/ https://www.ncbi.nlm.nih.gov/pubmed/30719309 http://dx.doi.org/10.1177/2050313X18823454

Ejemplares similares

Remission of type 2 diabetes in a hypogonadal man under long-term testosterone therapy
por: Haider, Ahmad, et al.
Publicado: (2017)

Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study
por: Haider, Karim Sultan, et al.
Publicado: (2020)

SUN-083 Hypertension and Hemodynamic Parameters in Men with Hypogonadism Improve Under Long-Term Treatment with Testosterone Undecanoate Injections (TU) Compared to Untreated Hypogonadal Control Patients
por: Saad, Farid, et al.
Publicado: (2019)

Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men
por: Saad, Farid, et al.
Publicado: (2015)

Effects of Long-Term Testosterone Therapy on Patients with “Diabesity”: Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes
por: Haider, Ahmad, et al.
Publicado: (2014)

MON-091 Profound and Sustained Weight Loss in Men With Hypogonadism and Obesity Receiving Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

SUN-226 Improvements In Quality Of Life In Men With Hypogonadism Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): Experience From 6,500 Patient-years Ina Registry Study Ina Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

SAT-533 Men with Hypogonadism and Osteoporosis Benefit from Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU) Regardless of Co-Medication with Bisphosphonates: 10-Year Data from a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

SUN-055 Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism Treated with Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Saad, Farid, et al.
Publicado: (2019)

OR21-2 Lipid Profiles Improve in Men With Hypogonadism and Pre-existing Cardiovascular Disease Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): 10-year Data From a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

Late-onset hypogonadism: beyond testosterone
por: Foresta, Carlo, et al.
Publicado: (2015)

Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups
por: Traish, Abdulmaged M., et al.
Publicado: (2017)

Commentary on “Late-onset hypogonadism - beyond testosterone”
por: Hackett, Geoffrey
Publicado: (2015)

Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study
por: Traish, A M, et al.
Publicado: (2014)

Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism
por: Almehmadi, Yousef, et al.
Publicado: (2016)

Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data
por: Alwani, Mustafa, et al.
Publicado: (2021)

Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms
por: Saad, Farid, et al.
Publicado: (2018)

The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
por: Shin, Yu Seob, et al.
Publicado: (2019)

Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study
por: Haider, Ahmad, et al.
Publicado: (2016)

An approach that someday may boost testosterone biosynthesis in males with late-onset hypogonadism (low testosterone)
por: Lamb, Dolores J.
Publicado: (2019)

Symptomatic late-onset hypogonadism but normal total testosterone: the importance of testosterone annual decrease velocity
por: La Vignera, Sandro, et al.
Publicado: (2020)

SUN-LB114 Remission of Type 2 Diabetes (DMT2) in Hypogonadal Men Under Long-Term Testosterone Therapy
por: Mskhalaya, George, et al.
Publicado: (2020)

Late-onset hypogonadism
por: Dudek, Piotr, et al.
Publicado: (2017)

Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies
por: Saad, F, et al.
Publicado: (2016)

Who are the fair candidates for testosterone replacement therapy in patients with late-onset hypogonadism symptoms?
por: Amano, Toshiyasu
Publicado: (2023)

Serum Total Testosterone Level and Identification of Late-Onset Hypogonadism: A Community-Based Study
por: Kang, Sungmin, et al.
Publicado: (2013)

Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study
por: Saad, F., et al.
Publicado: (2020)

Long-term Opioids Linked to Hypogonadism and the Role of Testosterone Supplementation Therapy
por: Marudhai, Suganya, et al.
Publicado: (2020)

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
por: de Almeida Ferreira, Maurício, et al.
Publicado: (2022)

Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy
por: Davidiuk, Andrew J., et al.
Publicado: (2016)

Testosterone replacement alters the cell size in visceral fat but not in subcutaneous fat in hypogonadal aged male rats as a late-onset hypogonadism animal model
por: Abdelhamed, Amr, et al.
Publicado: (2015)

New perspectives in functional hypogonadotropic hypogonadism: beyond late onset hypogonadism
por: Spaziani, Matteo, et al.
Publicado: (2023)

Predictive factors for efficacy of testosterone replacement therapy for late-onset hypogonadism in Japanese men: a preliminary report
por: Kondoh, Nobuyuki, et al.
Publicado: (2023)

Is there a relationship between the severity of erectile dysfunction and the comorbidity profile in men with late onset hypogonadism?
por: Yassin, Aksam A., et al.
Publicado: (2015)

Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010)

Late-Onset Hypogonadism as Primary Testicular Failure
por: Swee, Du Soon, et al.
Publicado: (2019)

Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes
por: Hanefeld, Markolf
Publicado: (2007)

Diagnosis and Treatment of Sexual Dysfunctions in Late-Onset Hypogonadism
por: Kim, Jin Wook, et al.
Publicado: (2011)

Practice guideline for pharmacists: The management of late-onset hypogonadism
por: Matai, Aakriti, et al.
Publicado: (2021)

The role of clomiphene citrate in late onset male hypogonadism
por: Ros, Carlos Teodósio Da, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1sl3rv7p4omvl30sqr6amphpp5